Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy.

Inactivation of gamma-aminobutric acid (GABA) as a neurotransmitter is mediated by diffusion in the synaptic cleft followed by binding to transporter sites and translocation into the intracellular compartment. The GABA transporters of which four subtypes have been cloned (GAT1-4) are distributed at presynaptic nerve endings as well as extrasynaptically on astrocytic and neuronal elements. This anatomical arrangement of the transporters appears to be of critical functional importance for the maintenance of GABAergic neurotransmission. Pharmacological characterization of the GABA transporters using a large number of GABA analogs having restricted conformation and lipophilic character has been of instrumental importance for elucidation of the functional importance of the different transporters. One such analog EF1502 (N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-hydroxy-4-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol) has been shown to selectively inhibit GAT1 (GABA transporter 1) and GAT2/BGT-1 (betaine/GABA transporter). Moreover, this GABA analog exhibits an unusually high efficiency as an anticonvulsant suggesting a novel role of the betaine/GABA transporter in epileptic seizure control. It is hypothesized that extrasynaptic actions of GABA may be involved in this phenomenon.

[1]  Juliette Johnson,et al.  Multiple γ‐aminobutyric acid plasma membrane transporters GAT‐1, GAT‐2, GAT‐3 in the rat retina , 1996 .

[2]  T. Branchek,et al.  Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study. , 1995, Brain research. Molecular brain research.

[3]  A. Schousboe,et al.  Anticonvulsant activity of intracerebroventricularly administered glial GABA uptake inhibitors and other GABAmimetics in chemical seizure models , 1989, Epilepsy Research.

[4]  C. Tanaka,et al.  Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry. , 1994, Brain research. Molecular brain research.

[5]  C. Thomsen,et al.  1‐(3‐(9H‐Carbazol‐9‐yl)‐1‐propyl)‐4‐(2‐methoxyphenyl)‐4‐piperidinol, a novel subtype selective inhibitor of the mouse type II GABA‐transporter , 1997, British journal of pharmacology.

[6]  P. Eriksson,et al.  Amino acid and monoamine transport in primary astroglial cultures from defined brain regions , 1985, Neurochemical Research.

[7]  A. Schousboe,et al.  Primary Cultures of Gabaergic and Glutamatergic Neurons as Model Systems to Study Neurotransmitter Functions I. Differentiated Cells , 1987 .

[8]  T. Branchek,et al.  Cloning and Expression of a Betaine/GABA Transporter from Human Brain , 1995, Journal of neurochemistry.

[9]  A. Reichenbach,et al.  High‐affinity GABA uptake in retinal glial (Müller) cells of the guinea pig: Electrophysiological characterization, immunohistochemical localization, and modeling of efficiency , 2002, Glia.

[10]  A. Najlerahim,et al.  Distribution of mRNA for the GABA transporter GAT-1 in the rat brain: evidence that GABA uptake is not limited to presynaptic neurons. , 1994, Journal of anatomy.

[11]  C. Kaiser,et al.  Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake , 1985 .

[12]  A. Schousboe,et al.  Heterocyclic GABA analogues as new selective inhibitors of astroglial GABA transport , 1981 .

[13]  A. Schousboe,et al.  Action of bicyclic isoxazole GABA analogues on GABA transporters and its relation to anticonvulsant activity. , 1999, European journal of pharmacology.

[14]  A. Schousboe,et al.  Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons , 1988, Epilepsy Research.

[15]  H. Lester,et al.  GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus. , 2003, Journal of neurophysiology.

[16]  N. Nelson,et al.  Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected]. , 1993, The Journal of biological chemistry.

[17]  A. Schousboe,et al.  Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission , 2004, Neurochemistry International.

[18]  J. Henley,et al.  Glutamate and GABA Receptors and Transporters. , 2002 .

[19]  X. Yan,et al.  Developmental expression of gamma-aminobutyric acid transporters (GAT-1 and GAT-3) in the rat cerebellum: evidence for a transient presence of GAT-1 in Purkinje cells. , 1998, Brain research. Developmental brain research.

[20]  N. Brecha,et al.  GAT-3, a High-Affinity GABA Plasma Membrane Transporter, Is Localized to Astrocytic Processes, and It Is Not Confined to the Vicinity of GABAergic Synapses in the Cerebral Cortex , 1996, The Journal of Neuroscience.

[21]  Istvan Mody,et al.  Distinguishing Between GABAA Receptors Responsible for Tonic and Phasic Conductances , 2001, Neurochemical Research.

[22]  A. Ducati,et al.  Neuronal and glial localization of GAT‐1, a high‐affinity γ‐aminobutyric acid plasma membrane transporter, in human cerebral cortex: With a note on its distribution in monkey cortex , 1998 .

[23]  A. Schousboe,et al.  Anticonvulsant activity of the gamma-aminobutyric acid uptake inhibitor N-4,4-diphenyl-3-butenyl-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol . , 1993, European journal of pharmacology.

[24]  A. Schousboe,et al.  Characterization of the Substrate-Binding Site in GABA Transporters , 2004 .

[25]  A. Schousboe,et al.  Selective inhibitors of glial GABA uptake: synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. , 1999, Journal of medicinal chemistry.

[26]  A. Schousboe,et al.  Transport and Metabolism of 7‐Aminobutyric Acid in Neurons and Glia: Implications for Epilepsy , 1983, Epilepsia.

[27]  A. Draguhn,et al.  Presence of γ-aminobutyric acid transporter mRNA in interneurons and principal cells of rat hippocampus , 2000, Neuroscience Letters.

[28]  Arne Schousboe,et al.  Correlation between Anticonvulsant Activity and Inhibitory Action on Glial γ-Aminobutyric Acid Uptake of the Highly Selective Mouse γ-Aminobutyric Acid Transporter 1 Inhibitor 3-Hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and ItsN-Alkylated Analogs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[29]  Arne Schousboe,et al.  Compartmentation of Glutamine, Glutamate, and GABA Metabolism in Neurons and Astrocytes: Functional Implications , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[30]  L. Yunger,et al.  Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. , 1984, The Journal of pharmacology and experimental therapeutics.

[31]  A. Schousboe,et al.  Effects of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazol (exo-THPO) and its N-substituted analogs on GABA transport in cultured neurons and astrocytes and by the four cloned mouse GABA transporters , 2003, Neurochemistry International.

[32]  M. Caplan,et al.  Polarized Expression of GABA Transporters in Madin-Darby Canine Kidney Cells and Cultured Hippocampal Neurons (*) , 1996, The Journal of Biological Chemistry.

[33]  C. Ribak,et al.  Astrocytic processes compensate for the apparent lack of GABA transporters in the axon terminals of cerebellar Purkinje cells , 1996, Anatomy and Embryology.

[34]  A. Schousboe,et al.  Demonstration of Pyruvate Recycling in Primary Cultures of Neocortical Astrocytes but Not in Neurons , 2002, Neurochemical Research.

[35]  A. Fink-Jensen,et al.  Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1 , 1997, Epilepsy Research.

[36]  Arne Schousboe,et al.  GABA transporters and GABA-transaminase as drug targets. , 2003, Current drug targets. CNS and neurological disorders.

[37]  Arne Schousboe,et al.  GABA transporters: functional and pharmacological properties , 2001 .

[38]  S. Quake,et al.  Number, Density, and Surface/Cytoplasmic Distribution of GABA Transporters at Presynaptic Structures of Knock-In Mice Carrying GABA Transporter Subtype 1–Green Fluorescent Protein Fusions , 2002, The Journal of Neuroscience.

[39]  M. Norenberg,et al.  Fine structural localization of glutamine synthetase in astrocytes of rat brain , 1979, Brain Research.

[40]  A. Bendahan,et al.  Purification and identification of the functional sodium- and chloride-coupled gamma-aminobutyric acid transport glycoprotein from rat brain. , 1986, The Journal of biological chemistry.

[41]  Ana Gadea,et al.  Glial transporters for glutamate, glycine and GABA I. Glutamate transporters , 2001, Journal of neuroscience research.

[42]  N. Nelson,et al.  Expression of a mouse brain cDNA encoding novel gamma-aminobutyric acid transporter. , 1992, The Journal of biological chemistry.

[43]  N. Brecha,et al.  GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  Nils Ole Dalby,et al.  Inhibition of gamma-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures. , 2003, European journal of pharmacology.

[45]  C. Ribak,et al.  GABA plasma membrane transporters, GAT‐1 and GAT‐3, display different distributions in the rat hippocampus , 1996 .

[46]  C. Ribak,et al.  Increased expression of GABA transporters, GAT-1 and GAT-3, in the deafferented superior colliculus of the rat , 1998, Brain Research.

[47]  H. Sarkar,et al.  Cloning, expression, and localization of a mouse retinal gamma-aminobutyric acid transporter. , 1994, Investigative ophthalmology & visual science.

[48]  Scott Slough,et al.  First Demonstration of a Functional Role for Central Nervous System Betaine/γ-Aminobutyric Acid Transporter (mGAT2) Based on Synergistic Anticonvulsant Action among Inhibitors of mGAT1 and mGAT2 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[49]  A. Schousboe,et al.  Pyruvate Carboxylase Activity in Primary Cultures of Astrocytes and Neurons , 1983, Journal of neurochemistry.

[50]  A. Schousboe,et al.  Anticonvulsant activity of the glial GABA uptake inhibitor, THAO, in chemical seizures. , 1989, European journal of pharmacology.

[51]  N. Brecha,et al.  Immunoreactivity for the GABA transporter-1 and GABA transporter-3 is restricted to astrocytes in the rat thalamus. A light and electron-microscopic immunolocalization , 1998, Neuroscience.

[52]  Paola S. Timiras,et al.  Model Systems of Development and Aging of the Nervous System , 1987, Springer US.

[53]  H. Lester,et al.  Cloning and expression of a rat brain GABA transporter. , 1990, Science.

[54]  N. Brecha,et al.  Expression of GAT‐1, a high‐affinity gamma‐aminobutyric acid plasma membrane transporter in the rat retina , 1994, The Journal of comparative neurology.

[55]  N. Brecha,et al.  Neuronal and glial localization of the GABA transporter GAT‐1 in the cerebellar cortex , 1996, Neuroreport.

[56]  P. Krogsgaard‐Larsen,et al.  INHIBITION OF GABA UPTAKE IN RAT BRAIN SLICES BY NIPECOTIC ACID, VARIOUS ISOXAZOLES AND RELATED COMPOUNDS , 1975, Journal of neurochemistry.

[57]  A. Schousboe,et al.  Anticonvulsant activity of the glial-selective GABA uptake inhibitor, THPO , 1983, Neuropharmacology.

[58]  M. Tohyama,et al.  Regional distribution of GABA transporter 1 (GAT1) mRNA in the rat brain: comparison with glutamic acid decarboxylase67 (GAD67) mRNA localization. , 1997, Brain research. Molecular brain research.